Skip to content
1st Counsel – Lifestyle
Author:
Bionano Genomics
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
August 24, 2026
Bionano Reports Second Quarter 2026 Results and Provides a Business Update
August 10, 2026
Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026
July 27, 2026
Bionano Announces Hiring of Chief Scientific Officer
June 24, 2026
Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption
June 18, 2026
Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders
June 11, 2026
Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures
May 28, 2026
Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia
May 26, 2026
Bionano Reports First Quarter 2026 Results and Provides a Business Update
May 13, 2026
Bionano Announces Leadership Transition
May 6, 2026
1
2
Next Page
→